Filing Details
- Accession Number:
- 0001179110-13-006726
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-04-12 09:16:23
- Reporting Period:
- 2013-04-10
- Filing Date:
- 2013-04-12
- Accepted Time:
- 2013-04-12 09:16:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
855654 | Immunogen Inc | IMGN | Pharmaceutical Preparations (2834) | 042726691 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1449753 | J James O'leary | C/O Immunogen, Inc. 830 Winter Street Waltham MA 02452 | Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-04-10 | 5,600 | $4.12 | 5,600 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-04-10 | 5,600 | $17.01 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-04-11 | 25,500 | $4.12 | 25,500 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-04-11 | 25,500 | $17.45 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2013-04-10 | 5,600 | $4.12 | 5,600 | $4.12 |
Common Stock | Stock Option (right ot buy) | Disposition | 2013-04-11 | 25,500 | $4.12 | 25,500 | $4.12 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
129,400 | 2009-11-07 | 2018-11-07 | No | 4 | M | Direct |
103,900 | 2009-11-07 | 2018-11-07 | No | 4 | M | Direct |
Footnotes
- Weighted average price of shares sold.
- The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan executed by the reporting person on September 10, 2012.
- Exercisable as to 37,500 shares commencing on November 7, 2009, 37,500 shares commencing on November 7, 2010, 37,500 shares commencing on November 7, 2011, and 37,500 shares commencing on November 7, 2012.